Table 2: Changes of activities in liver of EA-treated rats.

Control10 mg/kg EAChange (%)30 mg/kg EAChange (%)

EROD (pmol resorufin/min/mg prot.)6.24 ± 2.236.53 ± 1.525.58 ± 3.9711
MROD (pmol resorufin/min/mg prot.)8.39 ± 2.498.31 ± 1.077.33 ± 3.4013
C3ND (nmol HCHO/min/mg prot.)0.40 ± 0.140.39 ± 0.020.24 ± 1.27*40
EmND (nmol HCHO/min/mg prot.)1.96 ± 0.351.78 ± 0.85 10 1.22 ± 0.09*38
BPND (nmol HCHO/min/mg prot.)1.47 ± 0.401.29 ± 0.61 13 0.662 ± 0.308*55
BROD (pmol resorufin/min/mg prot.)2.61 ± 0.86 2.23 ± 1.20 15 2.03 ± 1.39* 23
PROD (pmol resorufin/min/mg prot.)6.51 ± 1.995.89 ± 0.907 10 4.60 ± 2.71*30
APND (nmol HCHO/min/mg prot.)0.339 ± 0.037 0.331 ± 0.031 0.154 ± 0.013*55
A4H (nmol p-aminophenol/min/mg prot.)0.344 ± 0.0140.245 ± 0.0828 0.145 ± 0.08*58
NDMA (nmol HCHO/min/mg prot.)0.405 ± 0.010.298 ± 0.1126 0.114 ± 0.17*56
ERND (nmol HCHO/min/mg prot.)0.117 ± 0.027 0.124 ± 0.021 0.085 ± 0.045*28
DBFOD (nmol fluorescein/min/mg prot.)6.66 ± 0.138 6.15 ± 0.427 5.12 ± 1.84*24
NQO1 (nmol/min/mg prot.)184 ± 10.25183 ± 9.49541 ± 23.18*194 ↑
GST-CDNB (nmol/min/mg prot.)559 ± 56.71561 ± 87.11835 ± 13.08*49 ↑
GST-DCNB (nmol/min/mg prot.)12.99 ± 4.2912.90 ± 8.1518.45 ± 3.93*42 ↑
GST-EA (nmol/min/mg prot.)10.35 ± 1.6110.32 ± 1.1113.79 ± 3.22*33 ↑
CAT (nmol/min/mg prot.)9.33 ± 0.299.25 ± 0.3315.37 ± 0.33*64 ↑
GPX (nmol/min/mg prot.)0.048 ± 0.0040.05 ± 0.0070.103 ± 0.003*114 ↑

 *Significantly different from the respective control value, .